2,925
edits
Natural therapeutics: Difference between revisions
→The endocannabinoid receptors: + 'The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?' a 2019 peer-reviewed review article published in Frontiers in Pharmacology
(→Migraines and cannabis: + 'Emerging Role of (Endo)Cannabinoids in Migraine', a 2018 mini-review, where they summarize recent discoveries and present new hypotheses on the role of cannabinoids in controlling trigeminal ....) |
(→The endocannabinoid receptors: + 'The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?' a 2019 peer-reviewed review article published in Frontiers in Pharmacology) |
||
| Line 44: | Line 44: | ||
Human body contains 2 types of endocannabinoid [[w:Cannabinoid receptor|receptors]] [[w:Cannabinoid receptor type 1|CB<sub>1</sub>]] and [[w:Cannabinoid receptor type 2|CB<sub>2</sub>]]. | Human body contains 2 types of endocannabinoid [[w:Cannabinoid receptor|receptors]] [[w:Cannabinoid receptor type 1|CB<sub>1</sub>]] and [[w:Cannabinoid receptor type 2|CB<sub>2</sub>]], but cannabinoids have interactions also on some other receptors. | ||
* [https://www.frontiersin.org/articles/10.3389/fphar.2019.00339/full 'The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?'] a 2019 peer-reviewed review article published in Frontiers in Pharmacology | |||
==== CB<sub>1</sub> receptors ==== | ==== CB<sub>1</sub> receptors ==== | ||